{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:57:18Z","timestamp":1781035038205,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":54,"publisher":"Springer New York","isbn-type":[{"value":"9781493994878","type":"print"},{"value":"9781493994885","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9488-5_21","type":"book-chapter","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:41:03Z","timestamp":1558705263000},"page":"273-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proteometabolomics of Melphalan Resistance in Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"David C.","family":"Koomen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy D.","family":"Guingab-Cagmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Meads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Meke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Eschrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Shain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,25]]},"reference":[{"issue":"7","key":"21_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"Shaji K. Kumar","year":"2018","unstructured":"Kumar SK, Rajkumar SV (2018) The multiple myelomas\u2013current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. https:\/\/doi.org\/10.1038\/s41571-018-0018-y","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"6","key":"21_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1074\/mcp.RA117.000543","volume":"17","author":"Vagisha Sharma","year":"2018","unstructured":"Sharma V, Eckels J, Schilling B, Ludwig C, Jaffe JD, MacCoss MJ, MacLean B (2018) Panorama public: a public repository for quantitative data sets processed in skyline. Mol Cell Proteomics. https:\/\/doi.org\/10.1074\/mcp.RA117.000543","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"21_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2017.1.498","volume":"2017","author":"MV Mateos","year":"2017","unstructured":"Mateos MV, San Miguel JF (2017) Management of multiple myeloma in the newly diagnosed patient. Hematology Am Soc Hematol Educ Program 2017(1):498\u2013507. https:\/\/doi.org\/10.1182\/asheducation-2017.1.498","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"21_CR4","first-page":"87","volume":"21","author":"DE Bergsagel","year":"1962","unstructured":"Bergsagel DE, Sprague CC, Austin C, Griffith KM (1962) Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-phenylalanine mustard (NSC-8806). Cancer Chemother Rep 21:87\u201399","journal-title":"Cancer Chemother Rep"},{"key":"21_CR5","first-page":"611","volume":"2","author":"J Bernard","year":"1962","unstructured":"Bernard J, Seligmann M, Danon F (1962) Attempt at treatment of 21 patients with myeloma or macroglobulinemia with p-di-2-chlorethylamino-1-phenylalanine (melphalan). Nouv Rev Fr Hematol 2:611\u2013616","journal-title":"Nouv Rev Fr Hematol"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/bjc.1963.53","volume":"17","author":"P Clifford","year":"1963","unstructured":"Clifford P, Clift RA, Gillmore JH (1963) Oral melphalan therapy in advanced malignant disease. Br J Cancer 17:381\u2013390","journal-title":"Br J Cancer"},{"issue":"6","key":"21_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cpt1979266737","volume":"26","author":"DS Alberts","year":"1979","unstructured":"Alberts DS, Chang SY, Chen HS, Evans TL, Moon TE (1979) Oral melphalan kinetics. Clin Pharmacol Ther 26(6):737\u2013745","journal-title":"Clin Pharmacol Ther"},{"issue":"29","key":"21_CR8","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1200\/JCO.2017.72.6679","volume":"35","author":"PL McCarthy","year":"2017","unstructured":"McCarthy PL, Holstein SA, Petrucci MT, Richardson PG, Hulin C, Tosi P, Bringhen S, Musto P, Anderson KC, Caillot D, Gay F, Moreau P, Marit G, Jung SH, Yu Z, Winograd B, Knight RD, Palumbo A, Attal M (2017) Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol 35(29):3279\u20133289. https:\/\/doi.org\/10.1200\/JCO.2017.72.6679","journal-title":"J Clin Oncol"},{"issue":"7","key":"21_CR9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/rcm.6515","volume":"27","author":"J Boschmans","year":"2013","unstructured":"Boschmans J, de Bruijn E, Van Schil P, Lemiere F (2013) Analysis of novel melphalan hydrolysis products formed under isolated lung perfusion conditions using liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 27(7):835\u2013841. https:\/\/doi.org\/10.1002\/rcm.6515","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"6","key":"21_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/rcm.7489","volume":"30","author":"D Dewaele","year":"2016","unstructured":"Dewaele D, Sobott F, Lemiere F (2016) Covalent adducts of melphalan with free amino acids and a model peptide studied by liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 30(6):719\u2013730. https:\/\/doi.org\/10.1002\/rcm.7489","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"21_CR11","first-page":"288","volume":"75","author":"G Carulli","year":"1990","unstructured":"Carulli G, Petrini M, Marini A, Ambrogi F, Ucci G, Riccardi A, Luoni R, Grassi B (1990) P-glycoprotein expression in multiple myeloma. Haematologica 75(3):288\u2013290","journal-title":"Haematologica"},{"issue":"1","key":"21_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bcp.2009.03.026","volume":"78","author":"A Kuhne","year":"2009","unstructured":"Kuhne A, Tzvetkov MV, Hagos Y, Lage H, Burckhardt G, Brockmoller J (2009) Influx and efflux transport as determinants of melphalan cytotoxicity: resistance to melphalan in MDR1 overexpressing tumor cell lines. Biochem Pharmacol 78(1):45\u201353. https:\/\/doi.org\/10.1016\/j.bcp.2009.03.026","journal-title":"Biochem Pharmacol"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/1471-2407-12-436","volume":"12","author":"VJ Spanswick","year":"2012","unstructured":"Spanswick VJ, Lowe HL, Newton C, Bingham JP, Bagnobianchi A, Kiakos K, Craddock C, Ledermann JA, Hochhauser D, Hartley JA (2012) Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples. BMC Cancer 12:436. https:\/\/doi.org\/10.1186\/1471-2407-12-436","journal-title":"BMC Cancer"},{"issue":"9","key":"21_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/2326-6066.CIR-15-0296","volume":"4","author":"M Ishibashi","year":"2016","unstructured":"Ishibashi M, Tamura H, Sunakawa M, Kondo-Onodera A, Okuyama N, Hamada Y, Moriya K, Choi I, Tamada K, Inokuchi K (2016) Myeloma drug resistance induced by binding of myeloma B7-H1 (PD-L1) to PD-1. Cancer Immunol Res 4(9):779\u2013788. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0296","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"21_CR15","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V72.6.2015.bloodjournal7262015","volume":"72","author":"B Barlogie","year":"1988","unstructured":"Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F (1988) Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 72(6):2015\u20132019","journal-title":"Blood"},{"issue":"4","key":"21_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-0609.2009.01403.x","volume":"84","author":"M Kaiser","year":"2010","unstructured":"Kaiser M, Lamottke B, Mieth M, Jensen MR, Quadt C, Garcia-Echeverria C, Atadja P, Heider U, von Metzler I, Turkmen S, Sezer O (2010) Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma. Eur J Haematol 84(4):337\u2013344. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01403.x","journal-title":"Eur J Haematol"},{"issue":"5","key":"21_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1600-0609.2012.01764.x","volume":"88","author":"B Lamottke","year":"2012","unstructured":"Lamottke B, Kaiser M, Mieth M, Heider U, Gao Z, Nikolova Z, Jensen MR, Sterz J, von Metzler I, Sezer O (2012) The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases. Eur J Haematol 88(5):406\u2013415. https:\/\/doi.org\/10.1111\/j.1600-0609.2012.01764.x","journal-title":"Eur J Haematol"},{"issue":"4","key":"21_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2141.2008.07217.x","volume":"142","author":"R Nimmanapalli","year":"2008","unstructured":"Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M (2008) HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma. Br J Haematol 142(4):551\u2013561. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07217.x","journal-title":"Br J Haematol"},{"issue":"9","key":"21_CR19","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3109\/10428194.2013.871277","volume":"55","author":"S Surget","year":"2014","unstructured":"Surget S, Lemieux-Blanchard E, Maiga S, Descamps G, Le Gouill S, Moreau P, Amiot M, Pellat-Deceunynck C (2014) Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other. Leuk Lymphoma 55(9):2165\u20132173. https:\/\/doi.org\/10.3109\/10428194.2013.871277","journal-title":"Leuk Lymphoma"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1038\/bcj.2014.45","volume":"4","author":"A Tagde","year":"2014","unstructured":"Tagde A, Singh H, Kang MH, Reynolds CP (2014) The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma. Blood Cancer J 4:e229. https:\/\/doi.org\/10.1038\/bcj.2014.45","journal-title":"Blood Cancer J"},{"issue":"1","key":"21_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ijo.2014.2726","volume":"46","author":"T Xiong","year":"2015","unstructured":"Xiong T, Wei H, Chen X, Xiao H (2015) PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA\/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226\/R. Int J Oncol 46(1):223\u2013232. https:\/\/doi.org\/10.3892\/ijo.2014.2726","journal-title":"Int J Oncol"},{"issue":"3","key":"21_CR22","first-page":"995","volume":"51","author":"WT Bellamy","year":"1991","unstructured":"Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM (1991) Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res 51(3):995\u20131002","journal-title":"Cancer Res"},{"issue":"7","key":"21_CR23","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1021\/ac500476a","volume":"86","author":"DR Jones","year":"2014","unstructured":"Jones DR, Wu Z, Chauhan D, Anderson KC, Peng J (2014) A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomics profiling and case study on drug-resistant multiple myeloma. Anal Chem 86(7):3667\u20133675. https:\/\/doi.org\/10.1021\/ac500476a","journal-title":"Anal Chem"},{"issue":"10","key":"21_CR24","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","volume":"75","author":"P Maiso","year":"2015","unstructured":"Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, Mishima Y, Asara JM, Roccaro AM, Kimmelman AC, Ghobrial IM (2015) Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 75(10):2071\u20132082. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3400","journal-title":"Cancer Res"},{"issue":"6","key":"21_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4172\/jpb.1000360","volume":"8","author":"CZ Ulmer","year":"2015","unstructured":"Ulmer CZ, Yost RA, Chen J, Mathews CE, Garrett TJ (2015) Liquid chromatography-mass spectrometry metabolic and lipidomic sample preparation workflow for suspension-cultured mammalian cells using jurkat T lymphocyte cells. J Proteomics Bioinform 8(6):126\u2013132. https:\/\/doi.org\/10.4172\/jpb.1000360","journal-title":"J Proteomics Bioinform"},{"issue":"6","key":"21_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chembiol.2011.04.011","volume":"18","author":"MP Patricelli","year":"2011","unstructured":"Patricelli MP, Nomanbhoy TK, Wu J, Brown H, Zhou D, Zhang J, Jagannathan S, Aban A, Okerberg E, Herring C, Nordin B, Weissig H, Yang Q, Lee JD, Gray NS, Kozarich JW (2011) In situ kinase profiling reveals functionally relevant properties of native kinases. Chem Biol 18(6):699\u2013710. https:\/\/doi.org\/10.1016\/j.chembiol.2011.04.011","journal-title":"Chem Biol"},{"issue":"5","key":"21_CR27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1021\/ja038441g","volume":"126","author":"GC Adam","year":"2004","unstructured":"Adam GC, Burbaum J, Kozarich JW, Patricelli MP, Cravatt BF (2004) Mapping enzyme active sites in complex proteomes. J Am Chem Soc 126(5):1363\u20131368. https:\/\/doi.org\/10.1021\/ja038441g","journal-title":"J Am Chem Soc"},{"issue":"2","key":"21_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1182\/blood-2004-11-4286","volume":"106","author":"Q Chen","year":"2005","unstructured":"Chen Q, Van der Sluis PC, Boulware D, Hazlehurst LA, Dalton WS (2005) The FA\/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Blood 106(2):698\u2013705. https:\/\/doi.org\/10.1182\/blood-2004-11-4286","journal-title":"Blood"},{"issue":"24","key":"21_CR29","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1158\/0008-5472.CAN-09-2616","volume":"69","author":"DN Yarde","year":"2009","unstructured":"Yarde DN, Oliveira V, Mathews L, Wang X, Villagra A, Boulware D, Shain KH, Hazlehurst LA, Alsina M, Chen DT, Beg AA, Dalton WS (2009) Targeting the Fanconi anemia\/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res 69(24):9367\u20139375. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2616","journal-title":"Cancer Res"},{"issue":"22","key":"21_CR30","first-page":"7900","volume":"63","author":"LA Hazlehurst","year":"2003","unstructured":"Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH, Saporta S, Boulware D, Moscinski L, Alsina M, Dalton WS (2003) Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 63(22):7900\u20137906","journal-title":"Cancer Res"},{"issue":"3","key":"21_CR31","doi-asserted-by":"publisher","first-page":"e0119857","DOI":"10.1371\/journal.pone.0119857","volume":"10","author":"KA Zub","year":"2015","unstructured":"Zub KA, Sousa MM, Sarno A, Sharma A, Demirovic A, Rao S, Young C, Aas PA, Ericsson I, Sundan A, Jensen ON, Slupphaug G (2015) Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells. PLoS One 10(3):e0119857. https:\/\/doi.org\/10.1371\/journal.pone.0119857","journal-title":"PLoS One"},{"issue":"11","key":"21_CR32","doi-asserted-by":"publisher","first-page":"M110 005520","DOI":"10.1074\/mcp.M110.005520","volume":"10","author":"Y Xiang","year":"2011","unstructured":"Xiang Y, Remily-Wood ER, Oliveira V, Yarde D, He L, Cheng JQ, Mathews L, Boucher K, Cubitt C, Perez L, Gauthier TJ, Eschrich SA, Shain KH, Dalton WS, Hazlehurst L, Koomen JM (2011) Monitoring a nuclear factor-kappaB signature of drug resistance in multiple myeloma. Mol Cell Proteomics 10(11):M110 005520. https:\/\/doi.org\/10.1074\/mcp.M110.005520","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"21_CR33","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/0006-2952(89)90499-1","volume":"38","author":"V Gupta","year":"1989","unstructured":"Gupta V, Singh SV, Ahmad H, Medh RD, Awasthi YC (1989) Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalan. Biochem Pharmacol 38(12):1993\u20132000","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"21_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0006-2952(91)90733-L","volume":"42","author":"RD Medh","year":"1991","unstructured":"Medh RD, Gupta V, Awasthi YC (1991) Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism. Biochem Pharmacol 42(2):439\u2013441","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"21_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00686114","volume":"34","author":"RT Mulcahy","year":"1994","unstructured":"Mulcahy RT, Bailey HH, Gipp JJ (1994) Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother Pharmacol 34(1):67\u201371","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"21_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/pmic.201400449","volume":"15","author":"S Tyanova","year":"2015","unstructured":"Tyanova S, Temu T, Carlson A, Sinitcyn P, Mann M, Cox J (2015) Visualization of LC-MS\/MS proteomics data in MaxQuant. Proteomics 15(8):1453\u20131456. https:\/\/doi.org\/10.1002\/pmic.201400449","journal-title":"Proteomics"},{"issue":"12","key":"21_CR37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.P.B.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26(12):1367\u20131372. https:\/\/doi.org\/10.1038\/nbt.1511","journal-title":"Nat Biotechnol"},{"issue":"9","key":"21_CR38","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13(9):2513\u20132526. https:\/\/doi.org\/10.1074\/mcp.M113.031591","journal-title":"Mol Cell Proteomics"},{"key":"21_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-6747-6_23","volume":"1550","author":"R Adusumilli","year":"2017","unstructured":"Adusumilli R, Mallick P (2017) Data conversion with ProteoWizard msConvert. Methods Mol Biol 1550:339\u2013368. https:\/\/doi.org\/10.1007\/978-1-4939-6747-6_23","journal-title":"Methods Mol Biol"},{"issue":"5","key":"21_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/bioinformatics\/btk039","volume":"22","author":"M Katajamaa","year":"2006","unstructured":"Katajamaa M, Miettinen J, Oresic M (2006) MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22(5):634\u2013636. https:\/\/doi.org\/10.1093\/bioinformatics\/btk039","journal-title":"Bioinformatics"},{"key":"21_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal T, Castillo S, Villar-Briones A, Oresic M (2010) MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11:395. https:\/\/doi.org\/10.1186\/1471-2105-11-395","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"21_CR42","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26(7):966\u2013968. https:\/\/doi.org\/10.1093\/bioinformatics\/btq054","journal-title":"Bioinformatics"},{"issue":"Web Server","key":"21_CR43","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia J, Psychogios N, Young N, Wishart DS (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37(Web Server):W652\u2013W660. https:\/\/doi.org\/10.1093\/nar\/gkp356","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"21_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS (2011) Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 6(6):743\u2013760. https:\/\/doi.org\/10.1038\/nprot.2011.319","journal-title":"Nat Protoc"},{"issue":"W1","key":"21_CR45","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0\u2013making metabolomics more meaningful. Nucleic Acids Res 43(W1):W251\u2013W257. https:\/\/doi.org\/10.1093\/nar\/gkv380","journal-title":"Nucleic Acids Res"},{"key":"21_CR46","doi-asserted-by":"publisher","first-page":"13 31 11","DOI":"10.1002\/cpbi.30","volume":"59","author":"AF Jarnuczak","year":"2017","unstructured":"Jarnuczak AF, Vizcaino JA (2017) Using the PRIDE database and ProteomeXchange for submitting and accessing public proteomics datasets. Curr Protoc Bioinformatics 59:13 31 11\u201313 31 12. https:\/\/doi.org\/10.1002\/cpbi.30","journal-title":"Curr Protoc Bioinformatics"},{"issue":"20","key":"21_CR47","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/pmic.201400120","volume":"14","author":"T Ternent","year":"2014","unstructured":"Ternent T, Csordas A, Qi D, Gomez-Baena G, Beynon RJ, Jones AR, Hermjakob H, Vizcaino JA (2014) How to submit MS proteomics data to ProteomeXchange via the PRIDE database. Proteomics 14(20):2233\u20132241. https:\/\/doi.org\/10.1002\/pmic.201400120","journal-title":"Proteomics"},{"issue":"9","key":"21_CR48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"MJ Hoon de","year":"2004","unstructured":"de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software. Bioinformatics 20(9):1453\u20131454. https:\/\/doi.org\/10.1093\/bioinformatics\/bth078","journal-title":"Bioinformatics"},{"issue":"17","key":"21_CR49","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","volume":"20","author":"AJ Saldanha","year":"2004","unstructured":"Saldanha AJ (2004) Java Treeview--extensible visualization of microarray data. Bioinformatics 20(17):3246\u20133248. https:\/\/doi.org\/10.1093\/bioinformatics\/bth349","journal-title":"Bioinformatics"},{"issue":"48","key":"21_CR50","doi-asserted-by":"publisher","first-page":"78896","DOI":"10.18632\/oncotarget.12969","volume":"7","author":"JG Turner","year":"2016","unstructured":"Turner JG, Kashyap T, Dawson JL, Gomez J, Bauer AA, Grant S, Dai Y, Shain KH, Meads M, Landesman Y, Sullivan DM (2016) XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IkappaBalpha and overcomes acquired proteasome inhibitor resistance in human multiple myeloma. Oncotarget 7(48):78896\u201378909. https:\/\/doi.org\/10.18632\/oncotarget.12969","journal-title":"Oncotarget"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"10690","DOI":"10.1038\/ncomms10690","volume":"7","author":"M Ramirez","year":"2016","unstructured":"Ramirez M, Rajaram S, Steininger RJ, Osipchuk D, Roth MA, Morinishi LS, Evans L, Ji W, Hsu CH, Thurley K, Wei S, Zhou A, Koduru PR, Posner BA, Wu LF, Altschuler SJ (2016) Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat Commun 7:10690. https:\/\/doi.org\/10.1038\/ncomms10690","journal-title":"Nat Commun"},{"issue":"13","key":"21_CR52","doi-asserted-by":"publisher","first-page":"24 11","DOI":"10.1002\/0471250953.bi1324s46","volume":"46","author":"JD Holman","year":"2014","unstructured":"Holman JD, Tabb DL, Mallick P (2014) Employing proteoWizard to convert raw mass spectrometry data. Curr Protoc Bioinformatics 46(13):24 11\u201324 19. https:\/\/doi.org\/10.1002\/0471250953.bi1324s46","journal-title":"Curr Protoc Bioinformatics"},{"key":"21_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-14-153","volume":"14","author":"EA Welsh","year":"2013","unstructured":"Welsh EA, Eschrich SA, Berglund AE, Fenstermacher DA (2013) Iterative rank-order normalization of gene expression microarray data. BMC Bioinformatics 14:153. https:\/\/doi.org\/10.1186\/1471-2105-14-153","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"21_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/0008-5472.CAN-13-2397","volume":"74","author":"ZP Khin","year":"2014","unstructured":"Khin ZP, Ribeiro ML, Jacobson T, Hazlehurst L, Perez L, Baz R, Shain K, Silva AS (2014) A preclinical assay for chemosensitivity in multiple myeloma. Cancer Res 74(1):56\u201367. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2397","journal-title":"Cancer Res"}],"container-title":["Methods in Molecular Biology","Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9488-5_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:18:28Z","timestamp":1574745508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9488-5_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493994878","9781493994885"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9488-5_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"25 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}